Lymphatic metastasis is a hallmark feature of papillary thyroid carcinoma (PTC), occurring in 30–80% of patients and significantly influencing clinical management. This review comprehensively examines the biological, anatomical, and clinical characteristics of lymphatic spread in PTC, focusing on its diagnostic and therapeutic implications. We detail the molecular mechanisms driving lymphangiogenesis, including the VEGF-C/VEGFR-3 axis and immune-evasion pathways, and highlight the distinct patterns of regional lymph node involvement—from central compartment (Level VI) to lateral (Levels II–V) and rare skip metastases. High-risk clinicopathological features, such as tumor size >2 cm, extrathyroidal extension, and aggressive histological variants, are discussed alongside molecular markers (BRAF V600E, TERT, RET/PTC) that predict metastatic potential. Management strategies are reviewed, balancing the benefits of prophylactic central neck dissection against its risks and emphasizing risk-adapted radioactive iodine therapy. Despite the frequency of lymphatic metastasis, its prognostic impact varies: microscopic nodal disease has minimal effect on survival, while macroscopic or extranodal extension increases recurrence and mortality risks. This synthesis of current evidence aims to guide clinicians in optimizing detection, treatment, and surveillance for PTC patients with lymphatic metastasis.
The cardiovascular system, a complex network vital for maintaining homeostasis, faces disorders such as cardiovascular diseases, impacting overall health. Heparin, a widely used anticoagulant, plays a crucial role in cardiovascular function by exerting multifaceted effects. This review explores heparin’s impact on the cardiovascular system, emphasizing its anticoagulant properties, modulation of endothelial function, anti-inflammatory effects, platelet inhibition, and influence on vascular remodeling. Heparin enhances antithrombin III activity, inhibiting key clotting factors and preventing thrombus formation. It preserves endothelial function by maintaining nitric oxide availability and protecting against oxidative stress. Heparin exhibits anti-inflammatory actions by suppressing cytokine production, inhibiting neutrophil activation, and mitigating leukocyte adhesion. Additionally, it interferes with vascular remodeling processes, inhibiting excessive extracellular matrix production and vascular smooth muscle cell proliferation. By directly inhibiting platelet function, heparin prevents aggregation and thrombus initiation. Understanding these mechanisms enhances our comprehension of heparin’s therapeutic utility in diverse cardiovascular conditions, emphasizing the importance of careful monitoring due to potential bleeding complications.
Artificial sweeteners, as low-calorie sugar substitutes, have attracted much attention in recent years, especially in terms of their potential health effects. Although they add almost no calories, studies have shown that artificial sweeteners may affect metabolism by stimulating insulin secretion and changing the intestinal microbiota, increasing the risk of metabolic syndrome and type 2 diabetes. Breast cancer, as the most common cancer in the world, is related to multiple factors such as genetics and hormone levels. The results of studies on artificial sweeteners and breast cancer risk are conflicting, with some showing a positive correlation between the two and others failing to confirm it. Differences in study design, participant characteristics, and the types of sweeteners have led to this ambiguity. Although some studies have focused on mechanisms such as hormone disorders, insulin response, and changes in the intestinal microbiota, further exploration is needed to establish a causal relationship. Our review aims to comprehensively analyze the potential association between artificial sweeteners and breast cancer and its mechanisms, as well as encourage future studies to reveal its long-term health effects.
Acute pancreatitis (AP) is a common acute abdomen and the number one cause of acute digestive hospitalizations in the United States. Abdominal pain is the main clinical manifestation of abdominal symptoms, so reducing the abdominal symptoms caused by inflammation is very important to alleviate the pain of patients. Electroacupuncture (EA) as a traditional Chinese medicine (TCM) therapy has significant conditioning effects on various inflammatory diseases including AP. Continuous studies in recent years have shown that EA conditioning has significant effects on reducing inflammation and regulating gastrointestinal symptoms in AP. At the same time, there is sufficient evidence to further elucidate the mechanism of EA. In this review, we will summarize the effect of EA on AP and its mechanism, so as to better serve clinical practice in the treatment of AP in the future.
4 January 2022 in European Journal of Clinical Investigation